Magazine
Subscribe
Submit Press Release
Issue Archives
Virtual Issue Archives
Special Sections
Reprints
NJBT E-News
About / Sign Up
Submit Press Release
Archives
NJB News Now
Sponsored Content
Industries
Accounting
Banking / Financial
Coronavirus
Economic Development
Energy
Environment
General Business
Government
Healthcare
High-Tech
Higher Ed
Infrastructure
Law
Meeting Places
Real Estate
Science & Technology
Small Business
Tourism
Workforce Development
Advertising
Upcoming Opportunities
Media Kit Request
File Upload
Ad Orbit Login
Awards
Awards for Excellence Nomination
2025 New Good Neighbor Nomination Form
About
NJB Magazine
NJBIA
Contact
Daily E-News Sign Up
Subscribe
Blog
Twitter
Facebook
Google
Linkedin
Magazine
Subscribe
Submit Press Release
Issue Archives
Virtual Issue Archives
Special Sections
Reprints
NJBT E-News
About / Sign Up
Submit Press Release
Archives
NJB News Now
Sponsored Content
Industries
Accounting
Banking / Financial
Coronavirus
Economic Development
Energy
Environment
General Business
Government
Healthcare
High-Tech
Higher Ed
Infrastructure
Law
Meeting Places
Real Estate
Science & Technology
Small Business
Tourism
Workforce Development
Advertising
Upcoming Opportunities
Media Kit Request
File Upload
Ad Orbit Login
Awards
Awards for Excellence Nomination
2025 New Good Neighbor Nomination Form
About
NJB Magazine
NJBIA
Contact
Tag
FDA
NJ Companies are on World’s Stage in Battle Against COVID-19
FDA Awards Certara’s Simcyp Division Two Grants
Certara Software or Services Supported 95% of FDA Novel Drug Approvals in First Half of 2018
Novartis and Amgen Announce FDA Approval of Aimovig
Eagle Pharmaceuticals Announces New Patents Issued for Bendeka
FDA Grants Breakthrough Therapy Designation to Immunomedics for Breast Cancer
EDDA Technology Introduces IQQA®-Guide Intra-Operative Precision 3D Navigation for Minimally Invasive and Robotic Surgical Treatment
FDA Awards $4.9M to Rutgers-Led Research Consortium to Expand Continuous Manufacturing in the Pharmaceutical Industry
Immunomedics Announces Orphan Drug Designation for Veltuzumab for the Treatment of Immune Thrombocytopenia
FDA Approves Deltoid Injection Site for Abilify Maintena
Immunomedics Awarded Fast Track Designation by FDA
FDA Approves Ipsen’s SOMATULINE® DEPOT (lanreotide) Injection
Merck Receives Accelerated Approval of KEYTRUDA® (pembrolizumab), the First FDA-Approved Anti-PD-1 Therapy
FDA Approves Merck’s BELSOMRA® (suvorexant) for the Treatment of Insomnia
Braeburn Pharmaceuticals to Initiate New Clinical Study for Probuphine Following Clear Guidance from FDA
Articles by Industry
Accounting
Banking / Financial
Coronavirus
Diversity
Economic Development
Economy
Energy
Environment
General Business
Government
Healthcare
High-Tech
Higher Ed
Infrastructure
Labor
Law
Life Sciences
Manufacturing
Meeting Places
New Hire/Promotion
Philanthropy
Real Estate
Science & Technology
Small Business
Tourism
Workforce Development
Special Sections
Sponsored Content
NEW JERSEY BUSINESS TODAY!
Join our Daily E-News Service
Email
(Required)
First Name
(Required)
Last Name
(Required)
Company
(Required)
Phone
This field is for validation purposes and should be left unchanged.
Δ